Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

CLINICAL DRUG INVESTIGATION is a prestigious journal dedicated to the fields of Medicine and Pharmacology, published by ADIS INT LTD in the United Kingdom. With an ISSN of 1173-2563 and an E-ISSN of 1179-1918, this journal has been a crucial contributor to the scientific community since its inception in 1995. Recognized for its significant impact, it holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories, placing it firmly in the 70th percentile within its field. Researchers, professionals, and students alike benefit from its commitment to publishing innovative studies and comprehensive reviews that advance understanding and application of clinical drugs. Although it does not currently offer open access options, its rigorous peer-review process ensures the integrity and quality of published articles. The journal's scope encompasses a wide range of topics related to drug investigation, making it an essential resource for anyone involved in medical research and pharmacological practice.

European Journal of Integrative Medicine is a prestigious academic publication under the esteemed Elsevier Science Inc., dedicated to advancing knowledge in the field of Complementary and Alternative Medicine. With an ISSN of 1876-3820 and an E-ISSN of 1876-3839, this journal serves as a pivotal platform for researchers, professionals, and students alike, aiming to explore the integration of holistic practices with conventional medicine. With a Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, and a commendable percentile of 75th, the journal underscores its significance in fostering scholarly discourse and supporting innovative research from 2009 to 2024. The European Journal of Integrative Medicine does not currently offer open access options, encouraging subscription-based access that promotes the quality of published research. This journal is subsequently an essential resource for anyone seeking to deepen their understanding of integrative health approaches and their clinical applications in contemporary medicine.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is a pivotal open-access journal published by Elsevier Science Inc., dedicated to the advancing field of clinical and experimental pharmacology. Established in 1959, this esteemed journal is committed to providing a platform for the dissemination of innovative research findings that span the entire spectrum of therapeutic sciences. With an impact factor that reflects its focus on enhancing medical knowledge and practice, CURRENT THERAPEUTIC RESEARCH serves a diverse audience of researchers, healthcare professionals, and students, striving to bridge the gap between laboratory research and clinical application. The journal has achieved a Q3 ranking in both the pharmacology and medical pharmacology categories, signifying its contribution to the field. With its open-access model initiated in 2006, it underscores the importance of research accessibility, ensuring that valuable insights reach a global audience. As the journal continues to evolve, it remains an essential resource for those devoted to improving therapeutic interventions and advancing healthcare outcomes through rigorous scientific inquiry.

Oral and Maxillofacial Surgery-Heidelberg, published by Springer Heidelberg, stands as a pivotal resource in the fields of oral surgery, otorhinolaryngology, and general surgery. With an ISSN of 1865-1550 and E-ISSN 1865-1569, this peer-reviewed journal has been contributing significant scholarly content since its inception in 2003, with a focus on advancing knowledge and practices through innovative research studies, clinical techniques, and reviews. As a recognized Q2 journal across multiple categories—including Oral Surgery, Otorhinolaryngology, and Surgery—it ranks prominently in Scopus rankings, reflecting its impact and relevance within the medical and dental communities. Despite its non-Open Access model, the journal remains important for researchers and professionals seeking cutting-edge insights and developments in maxillofacial surgery. With a commitment to enhancing clinical practices and patient outcomes, Oral and Maxillofacial Surgery-Heidelberg is an essential resource for those dedicated to advancing the field.

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

The Cochrane Database of Systematic Reviews is a premier journal published by WILEY, focusing on the critical appraisal and synthesis of high-quality research in health care. With its dedication to evidence-based practice, this journal serves as a cornerstone for researchers, healthcare professionals, and students alike, offering pivotal insights through rigorous systematic reviews. Although it is not an open-access publication, its influence in guiding clinical decision-making and policy formulation is profound, underscored by its contributions to the advancement of healthcare knowledge. Based in the United States at 111 River St, Hoboken, NJ, the Cochrane Database has established itself as essential reading for those seeking to stay at the forefront of systematic reviews and meta-analyses in the medical field, ensuring that users are well-equipped with the evidence necessary for informed practice.